Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 19431196.
- Also identified by DOI 10.1002/hed.21122.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Loss of p16 expression by promoter hypermethylation has been reported as an early event in the development of oral cancer. The aim of our study was to explore the prognostic implications of presence of promoter hypermethylation of p16 gene in surgical margins in carcinoma tongue. A prospective analysis of 38 patients with resectable carcinoma tongue was carried out. DNA from tumor and the surgical margins was assessed by methylation-specific polymerase chain reaction. Follow-up duration was 17 to 37 months. About 86.8% of tumors showed promoter hypermethylation of p16 gene. Out of 30 patients with histologically free margins, 43.3% showed positivity on molecular assessment. Patients with positive molecular margins had a 6.3-fold increased risk of having local recurrence as compared to patients with negative margins. Promoter hypermethylation of p16 gene may serve as a useful molecular marker for predicting local recurrence in carcinoma tongue.
Medical subject headings
- Carcinoma, Squamous Cell
- DNA Methylation
- Genes, p16
- Neoplasm Recurrence, Local
- Promoter Regions, Genetic
- Tongue Neoplasms